
Prediction of periprosthetic joint infection (PJI) after total knee arthroplasty (TKA) relies almost wholly on host factors, and whether the operation itself carries infection risk independent of the patient is unknown. We analyzed 2920 primary TKAs in 2350 patients from a single institution with national joint registry linkage, using death as a competing risk and coronal alignment as a negative-control exposure. A pre-specified surgical-complexity index counted five construct markers at the index operation: constraint, a tibial stem, a femoral stem, a previous implant and a pre-existing extra-articular deformity or fracture. Septic revision was the primary outcome and aseptic revision the control. Fine–Gray subdistribution hazard models with patient-level clustering estimated complexity and, in the paired-radiograph subset, neutral-alignment effects on both outcomes. There were 51 septic and 104 aseptic revisions and 525 deaths over a median follow-up of 7.4 years. Each additional complexity marker raised the subdistribution hazard of PJI (sHR 1.61, 95% CI 1.27–2.04) but not of aseptic revision (sHR 1.06, 95% CI 0.84–1.33); 5-year PJI incidence rose from 1.5% with zero or one marker to 5.9% with two or more. Neutral coronal alignment was protective against aseptic revision (sHR 0.42, 95% CI 0.26–0.67) but null for PJI (sHR 0.87, 95% CI 0.41–1.87). Adjustment for skin-to-skin operative time, available for 93% of the cohort, moved the complexity estimate in the same knees only from 1.58 to 1.55 and attributed 5 % of the effect to operative time. These are observational associations and not causal effects, but surgical exposure merits consideration alongside host factors in infection-risk assessment.
Introduction: Peri-prosthetic joint infection (PJI) is a significant complication of arthroplasty, lacking a single gold standard diagnostic test. Synovial fluid white blood cell (WBC) count and polymorphonuclear neutrophil (PMN) proportion are widely used diagnostic tools, but their optimal cutoffs remain unclear, particularly for chronic PJI. Material and methods: This systematic review and meta-analysis included 74 studies published between 2000 and 2024. Data on diagnostic performance (sensitivity, specificity, and diagnostic odds ratios – DORs) of WBC count and PMN proportions were analysed. Sub-group analyses and heterogeneity assessments were performed, and optimal cutoffs for diagnostic accuracy were identified. Results: The meta-analysis revealed a WBC count summary DOR of 58.38 (95 % CI – confidence interval: 48.48–70.32) with an area under the curve (AUC) of the summarized receiver operating characteristic curve of 0.952. The PMN proportion showed a DOR of 43.17 (95 % CI: 35.31–52.79) and an AUC of 0.941. Optimal diagnostic thresholds for chronic PJI were WBC count ≈ 1792 cells mL−1 (sensitivity 86 %, specificity 87 %) and PMN ≈ 67 % (sensitivity 89 %, specificity 86 %). No single threshold reached ≥ 95 % specificity or ≥ 95 % sensitivity: specificity was ≈ 91 % at WBC count ≥ 3000 cells mL−1 and ≈ 90 % at PMN ≥ 75 %, and sensitivity was ≈ 88 %–90 % at WBC count ≤ 1500 cells mL−1 and PMN ≤ 65 %. Confounding conditions such as fractures, inflammatory arthritis, and metal-related reactions reduced test accuracy. Conclusions: Synovial fluid analysis remains a critical diagnostic tool for chronic PJI. Lower thresholds (WBC count > 1500 cells mL−1; PMN > 65 %) are most useful for raising suspicion of infection and upper thresholds (WBC count >3000 cells mL−1; PMN > 75 %) for supporting it, although as single markers neither reaches the ≥ 95 % specificity. A standardized diagnostic framework is essential for addressing remaining controversies and ensuring consistent interpretation across clinical settings.
Background: Acute hematogenous periprosthetic joint infection after hip or knee arthroplasty is difficult to treat. The method of debridement, antibiotics, and implant retention (DAIR) is widely used, but reported success rates vary, and predictors of failure remain unclear. Methods: We searched PubMed, Scopus, Web of Science, and Embase from inception through 26 November 2025 for studies reporting outcomes of DAIR in acute hematogenous periprosthetic joint infection. Two reviewers independently screened studies, extracted data, and assessed methodological quality using Joanna Briggs Institute tools. The primary outcome was pooled treatment success. Results: Forty-nine studies were included in the qualitative synthesis. Reported success rates ranged from 20 % to 100 %, with a pooled success rate of 64.5 % (95 % confidence interval, 59.3 %–69.4 %; I2=72 %, τ2=0.44) in the meta-analysis. This pooled estimate describes an average across heterogeneous cohorts and should not be used as a patient-specific prediction. Success was higher in total hip arthroplasty than in total knee arthroplasty (69.4 % vs. 63.2 %). Outcomes improved over time, from 44.9 % before 2010 to 68.7 % in 2020–2025. Staphylococcus aureus infection and prolonged symptom duration before debridement were the most consistently reported predictors of treatment failure, whereas some included studies reported improved outcomes with modular component exchange. Conclusion: DAIR controls infection in about two-thirds of patients with acute hematogenous periprosthetic joint infection. Failure remains common, especially with S. aureus infection or delayed intervention, supporting early diagnosis, prompt surgery, and careful patient selection.
Prosthetic joint infection (PJI) following arthroplasty is associated with high morbidity and financial cost. Patients often undergo multiple complex procedures, prolonged inpatient stays and outpatient parenteral antibiotic therapy (OPAT). We aim to quantify the economic implications of the inpatient and OPAT costs of the management of private patients treated in the public healthcare system. Retrospective analysis of operative PJI cases between September 2020 and September 2025 was performed. Included patients were those who had primary total hip replacement (THR) or total knee replacement (TKR) for osteoarthritis or trauma. Data included inpatient stay, OPAT utilization, surgical procedures (debridement, antibiotics, and implant retention (DAIR); and revisions), and private/public status at index procedure. Costs were estimated using available Health Service Executive (HSE) information on operative costs and bed days. There were 40 operative PJI cases in our centre over the study period. There were 22 TKRs and 18 THRs. Eighteen had their initial surgery publicly, whereas 14 had their initial surgery privately. A total of 19 patients underwent DAIR while the rest underwent one or several revisions. Combined total length of stay was 1796 bed days. The operative PJI burden over that period was EUR 5 005 339 (median EUR 84 232 per episode) or approximately EUR 1 000 000 yr−1. Fourteen private patients treated in our centre had publicly funded treatment at an estimated cost of EUR 1 967 270 over a 5-year period or EUR 393 454 yr−1. Operative PJI imposes a substantial clinical and financial burden. Private patients treated in public hospitals contribute to the total costs, raising the justification for private healthcare contributions to publicly treated complications arising after private procedures.
Late fracture-related infection (FRI) after intramedullary nailing may extend beyond the fracture site to involve the medullary canal, nail entry site, and locking screw tracts. This retrospective cohort study evaluated a staged protocol incorporating systematic multi-regional debridement of the entire nail-related infection pathway. We reviewed 47 patients treated between January 2017 and January 2025, all of whom had fracture nonunion and an interval of at least 3 months from the first documented confirmation of FRI to admission. Stage I included intramedullary nail removal; systematic multi-regional debridement of the fracture/nonunion site, nail entry site, entire medullary canal, and proximal and distal locking screw tracts; locking plate fixation; and temporary vancomycin-loaded polymethyl methacrylate cement placement for dead-space management and induced membrane formation. Definitive Stage II reconstruction included the removal of the temporary plate construct and cement, repeat debridement, bone grafting, and definitive fixation with a new internal locking plate after clinical and laboratory infection quiescence and intraoperative reassessment. The cohort included 21 tibial and 26 femoral cases, with a mean follow-up of 25.3 ± 14.1 months. Two patients had confirmed persistent infection requiring repeat debridement before definitive Stage II reconstruction. No confirmed recurrence or unplanned surgical debridement for suspected recurrence occurred after definitive reconstruction. Union after the index Stage II reconstruction was achieved in 44 of 47 patients (93.6 %). The remaining three patients achieved union after further surgery, resulting in a final union rate of 100 %. The mean times to radiographic union and full weight-bearing were 9.7 ± 2.1 and 11.3 ± 3.8 months, respectively. Median (interquartile range) WBC count, ESR, and CRP decreased from 7.2 (6.2–9.0) × 109 L−1, 39.0 (12.5–65.0) mm h−1, and 26.5 (10.3–43.2) mg L−1 to 5.9 (5.0–7.7) × 109 L−1, 17.0 (8.0–29.5) mm h−1, and 6.3 (3.7–8.9) mg L−1, respectively. LEFS and SF-36 scores increased from 47.0 (37.0–65.5) and 417.0 (335.0–439.0) to 70.0 (61.0–75.5) and 491.0 (480.0–516.5), whereas VAS and SAS scores decreased from 4.0 (4.0–4.0) and 45.0 (42.0–50.0) to 1.0 (0.0–1.0) and 32.0 (29.5–37.0), respectively (all p≤0.001). These findings support the feasibility of this staged protocol in selected patients with late post-intramedullary-nailing FRI and nonunion.